These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
90 related articles for article (PubMed ID: 10381366)
21. Predictive role of the UGT1A1, UGT1A7, and UGT1A9 genetic variants and their haplotypes on the outcome of metastatic colorectal cancer patients treated with fluorouracil, leucovorin, and irinotecan. Cecchin E; Innocenti F; D'Andrea M; Corona G; De Mattia E; Biason P; Buonadonna A; Toffoli G J Clin Oncol; 2009 May; 27(15):2457-65. PubMed ID: 19364970 [TBL] [Abstract][Full Text] [Related]
22. The human UDP glucuronosyltransferase, UGT1A10, glucuronidates mycophenolic acid. Mojarrabi B; Mackenzie PI Biochem Biophys Res Commun; 1997 Sep; 238(3):775-8. PubMed ID: 9325166 [TBL] [Abstract][Full Text] [Related]
23. Effects of Japanese herbal medicine, Kampo, on human UGT1A1 activity. Katoh M; Yoshioka Y; Nakagawa N; Yokoi T Drug Metab Pharmacokinet; 2009; 24(3):226-34. PubMed ID: 19571434 [TBL] [Abstract][Full Text] [Related]
24. Differential and special properties of the major human UGT1-encoded gastrointestinal UDP-glucuronosyltransferases enhance potential to control chemical uptake. Basu NK; Ciotti M; Hwang MS; Kole L; Mitra PS; Cho JW; Owens IS J Biol Chem; 2004 Jan; 279(2):1429-41. PubMed ID: 14557274 [TBL] [Abstract][Full Text] [Related]
25. Irinotecan inactivation is modulated by epigenetic silencing of UGT1A1 in colon cancer. Gagnon JF; Bernard O; Villeneuve L; Têtu B; Guillemette C Clin Cancer Res; 2006 Mar; 12(6):1850-8. PubMed ID: 16551870 [TBL] [Abstract][Full Text] [Related]
26. Inhibition of UDP-glucuronosyltransferase by aglycons of natural glucuronides in kampo medicines using SN-38 as a substrate. Yokoi T; Narita M; Nagai E; Hagiwara H; Aburada M; Kamataki T Jpn J Cancer Res; 1995 Oct; 86(10):985-9. PubMed ID: 7493919 [TBL] [Abstract][Full Text] [Related]
27. Glucuronidation of OTS167 in Humans Is Catalyzed by UDP-Glucuronosyltransferases UGT1A1, UGT1A3, UGT1A8, and UGT1A10. Ramírez J; Mirkov S; House LK; Ratain MJ Drug Metab Dispos; 2015 Jul; 43(7):928-35. PubMed ID: 25870101 [TBL] [Abstract][Full Text] [Related]
28. The role of glucuronidation in 7-ethyl-10-hydroxycamptothecin resistance in vitro. Takahashi T; Fujiwara Y; Yamakido M; Katoh O; Watanabe H; Mackenzie PI Jpn J Cancer Res; 1997 Dec; 88(12):1211-7. PubMed ID: 9473740 [TBL] [Abstract][Full Text] [Related]
29. Expression of the human UGT1 locus in transgenic mice by 4-chloro-6-(2,3-xylidino)-2-pyrimidinylthioacetic acid (WY-14643) and implications on drug metabolism through peroxisome proliferator-activated receptor alpha activation. Senekeo-Effenberger K; Chen S; Brace-Sinnokrak E; Bonzo JA; Yueh MF; Argikar U; Kaeding J; Trottier J; Remmel RP; Ritter JK; Barbier O; Tukey RH Drug Metab Dispos; 2007 Mar; 35(3):419-27. PubMed ID: 17151188 [TBL] [Abstract][Full Text] [Related]
30. Inhibition of SN-38 glucuronidation by gefitinib and its metabolite. Li W; Xing Y; Liu Y Cancer Chemother Pharmacol; 2015 Jun; 75(6):1253-60. PubMed ID: 25917289 [TBL] [Abstract][Full Text] [Related]
31. Hepatic UDP-glucuronosyltransferases responsible for glucuronidation of thyroxine in humans. Kato Y; Ikushiro S; Emi Y; Tamaki S; Suzuki H; Sakaki T; Yamada S; Degawa M Drug Metab Dispos; 2008 Jan; 36(1):51-5. PubMed ID: 17908920 [TBL] [Abstract][Full Text] [Related]
32. Glucuronidation of edaravone by human liver and kidney microsomes: biphasic kinetics and identification of UGT1A9 as the major UDP-glucuronosyltransferase isoform. Ma L; Sun J; Peng Y; Zhang R; Shao F; Hu X; Zhu J; Wang X; Cheng X; Zhu Y; Wan P; Feng D; Wu H; Wang G Drug Metab Dispos; 2012 Apr; 40(4):734-41. PubMed ID: 22238289 [TBL] [Abstract][Full Text] [Related]
34. Characterization of the UDP glucuronosyltransferase activity of human liver microsomes genotyped for the UGT1A1*28 polymorphism. Zhang D; Zhang D; Cui D; Gambardella J; Ma L; Barros A; Wang L; Fu Y; Rahematpura S; Nielsen J; Donegan M; Zhang H; Humphreys WG Drug Metab Dispos; 2007 Dec; 35(12):2270-80. PubMed ID: 17898154 [TBL] [Abstract][Full Text] [Related]
35. Glucuronidation of 1'-hydroxyestragole (1'-HE) by human UDP-glucuronosyltransferases UGT2B7 and UGT1A9. Iyer LV; Ho MN; Shinn WM; Bradford WW; Tanga MJ; Nath SS; Green CE Toxicol Sci; 2003 May; 73(1):36-43. PubMed ID: 12657745 [TBL] [Abstract][Full Text] [Related]
36. In vitro glucuronidation of thyroxine and triiodothyronine by liver microsomes and recombinant human UDP-glucuronosyltransferases. Tong Z; Li H; Goljer I; McConnell O; Chandrasekaran A Drug Metab Dispos; 2007 Dec; 35(12):2203-10. PubMed ID: 17875670 [TBL] [Abstract][Full Text] [Related]
37. Inducibility of UDP-glucuronosyltransferase 1As by beta-naphthoflavone in HepG2 cells. Hanioka N; Obika N; Nishimura M; Jinno H; Tanaka-Kagawa T; Saito K; Kiryu K; Naito S; Narimatsu S Food Chem Toxicol; 2006 Aug; 44(8):1251-60. PubMed ID: 16545899 [TBL] [Abstract][Full Text] [Related]
38. Identification of the rabbit liver UDP-glucuronosyltransferase catalyzing the glucuronidation of 4-ethoxyphenylurea (dulcin). Uesawa Y; Staines AG; O'Sullivan A; Mohri K; Burchell B Drug Metab Dispos; 2004 Dec; 32(12):1476-81. PubMed ID: 15448114 [TBL] [Abstract][Full Text] [Related]
39. Isoliquiritigenin showed strong inhibitory effects towards multiple UDP-glucuronosyltransferase (UGT) isoform-catalyzed 4-methylumbelliferone (4-MU) glucuronidation. Lu H; Fang ZZ; Cao YF; Hu CM; Hong M; Sun XY; Li H; Liu Y; Fu X; Sun H Fitoterapia; 2013 Jan; 84():208-12. PubMed ID: 23237733 [TBL] [Abstract][Full Text] [Related]
40. Quaternary ammonium-linked glucuronidation of 1-substituted imidazoles: studies of human UDP-glucuronosyltransferases involved and substrate specificities. Vashishtha SC; Hawes EM; McKay G; McCann DJ Drug Metab Dispos; 2001 Oct; 29(10):1290-5. PubMed ID: 11560872 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]